Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Boomskidon Dec 27, 2022 5:49pm
85 Views
Post# 35192856

RE:RE:The Play Is for xB3

RE:RE:The Play Is for xB3Why are these big players, including a billionaire, buying Bioasis, zwerp2000? If xB3 has no value, then Cresence EGF is all that is left, so why would they go through all these machinations to get EGF?. 

LT and the players could have bought Cresence without bothering with Bioasis. It was likley LT who who set up the Cresence deal, probably as a tactic to remove the focus on xB3.

They didn't buy Cresence becase they didn't want it. Compared to xB3, Cresence is worthless. (6 million Bioasis shares, not even a million dollars - Canadian!

If both xB3 and EGF are worthless then Midatech is a pump and dump, pumped on the false value of xB3 and how xB3 could advance the Midatech and EGF programs.

But that's dangerous. It has objectives that big players like LT and Armistice usually wouldn't consider, the pumping and dumping of a small play like this, that nevertheless lives under the scrutiny of three exchanges and their associated securities regulators.

Nope. This is a play for xB3.

They want it and they got it.

JD 
<< Previous
Bullboard Posts
Next >>